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Abstract: Tilapia (Oreochromis niloticus Linnaeus, 1758) were infected with Streptococcus iniae (Cat No: ATCC 29178)
and the plasma changes in the acute phase protein (APP) members were examined at different time periods. A total
of 72 fish with average body weights of 60 g were used. Fish in the infected group (group I) were intraperitoneally
injected with S. iniae at 3.3 × 105 colony forming unit (CFU) in 0.1 mL level to the fish. The other group (group II) was
subjected to handling stress near the infection. The control group was constituted by providing optimum conditions.
On days 7, 14, and 21, blood samples were taken from the caudal veins of the fish under the appropriate anesthesia. The
samples were examined on the basis of APPs, C-reactive protein (CRP), fibrinogen (FB), serum amyloid A (SAA), and
transferrin (TF) and the changes in the plasma values were recorded. The internal and external symptoms seen during
the examinations were detected as follows: the color concentration in 1-2 days in the infected groups, irregularity and
retardation in the movements of the fish, hyperemic spots on the skin, and bloody effusion in the internal organs. In
both of the infected groups, the CRP and SAA plasma values increased on days 7, 14, and 21 (P < 0.05). Remission was
observed in the plasma TF levels in the first week; however, after the second week the levels reached normal values.
Decreases in the FB levels of all of the samples were detected. Based on the data acquired in this study, it was concluded
that changes in the plasma levels of the APP members can be used as a significant bioindicator in the pathogenesis of
the disease in fish infections.
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Introduction
Fish are among the most important sources of protein
for human consumption; thus fish farming is one of
the fastest growing segments of animal production in
the world (1). However, stress and infectious diseases
are among the most notable constraints on the
expansion of aquaculture and the realization of its
full potential; thus the study of the signs and lesions
induced by fish diseases helps to protect our national
economy (2,3).
* E-mail: agulec@tunceli.edu.tr
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The acute phase response (APR) is a pervasive
physiological response of the body to injury, trauma,
or infection (4,5) and has been defined as “the entire
array of metabolic and physiological changes which
occur in response to tissue injury or infection” (5). The
APR, with its changes in blood plasma composition,
is thought to be beneficial to the organism by
preventing microbial growth and helping to restore
homeostasis.
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The APR is best characterized by dramatic changes
in the concentration of a group of plasma proteins
known as acute phase proteins (APPs), which are
synthesized in the liver (5). Some APPs opsonize
microorganisms and activate complement [serum
amyloid-A (SAA) and C-reactive protein (CRP)]
proteins, while others scavenge cellular remnants
and free radicals, or neutralize proteolytic enzymes
[fibrinogen (FB) and transferrin (TF)].
The innate arm of the immune system responds to
inflammatory stimuli by the activation of phagocytes,
and by altered levels of several plasma proteins. These
changes in the plasma proteins have drawn attention
to the importance of the innate immune response
in fish. Specifically, APPs are established diagnostic
tools as early indicators of inflammation and disease
(6) and many are now known to play beneficial roles
in mediating the complex inflammatory response
and seeking to restore homeostasis (5). Some APPs
to viral, bacterial, and fungal inflammatory agents
were also isolated from rainbow trout (7,8) and an
expression analysis of the acute phase response
after infection with a gram-negative bacterium were
isolated from channel catfish (9) and zebra fish (10).
However, there is no information on the progress
of the APR in tilapia (Oreochromis niloticus). Tilapia
farms in many parts of the world suffer heavy losses
due to bacterial pathogens. Streptococcus spp. are the
most serious disease problems in tilapia production,
causing 80% of fish mortalities (2,11,12) and have
been recently listed among the emerging problems in
aquaculture (13).
S. iniae is recognized as one of the most dangerous
members of this genus, causing lethal infections in
both freshwater and marine fish (14). Infection by S.
iniae generally develops into septicemia, but clinical
signs, pathology, and virulence of the disease vary in
different hosts (15).
S. iniae has been an important model for
immunological studies (16,17). Recently, tilapia
has also been recognized as a valuable model to
understand immunity (12,18). Many inferences have
been made on various factors (stressors), which
influence mortality due to streptococcal disease
caused by S. iniae (3,19).

Determination of APPs can help in monitoring
the health of individual subjects, especially when
several acute phase variables are combined in an
index. The acute phase reaction offers a biological
effect mechanism appropriate to include in future
systems for assessing health in animals and human
patients.
The objective of this study was to determine
some APPs developing in tilapia individuals after
experimentally infection with S, iniae, in order to
better diagnose S. iniae infections in tilapia.
Materials and methods
Tilapia care and maintenance
Tilapia, at an average weight of 60 g and length of
14 cm, were used as experimental animals. The study
was conducted at the investigation station of the
General Directorate of the State Hydraulic Works
(DSI), between May and October. Fish used in the
experiment were obtained from the fish farm of the
DSI in Adana, Turkey. A sample of fish was culture
negative for S. iniae by standard methods (12), prior
to experimentation. Fish were stocked into 1.5 ×
2.5 × 1 m tanks supplied with water at 26.2 ± 0.799
°C and a daily dissolved oxygen level of 5.4 ± 0.449
mg/L. The fish were fed carp feed at 2%-3% body
weight daily and kept under a light/dark photoperiod
of 12:12. The fish were stocked in 3 replicates per
treatment at a density of 8 fish per tank. All of the fish
were acclimatized for a minimum of 1 month prior
to experimentation and were free from any active
infections.
Cultivation of Streptococcus iniae
Overnight cultures of S. iniae were diluted at a ratio of
1:50 in nutrition broth. Briefly, the isolate of S. iniae,
taken from a blood agar plate, was grown in ToddHewitt broth (THB) (Difco Laboratories, Detroit,
MI, USA) for 24 h prior to use, and harvested in the
logarithmic phase of growth. The cells were washed
once in sterile THB, resuspended, and then diluted
to the appropriate concentration in sterile THB.
The bacterial concentration was determined using a
colony forming unit (CFU) per milliliter by plating
serial dilutions onto BHI agar plates.
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Identification methods
Morphological characteristics of S. iniae were obtained
by growing them on THB and brain heart infusion
agar (BHIA) (Difco) plates at 30 °C, incubated for 24
h, and visualized by light microscopy.
Routine microbiological testing procedures were
used to confirm the species identification of the S.
iniae strain. The identity of the isolated strain was
tested using standard biochemical identification
media incubated at 25 °C for 48 h (20). Bacteriological
methods for the isolation, culture, and biochemical
identification of S. iniae were applied also as described
by Bilgehan (20).
The rapid ID 32 Strep (BioMerieux, France) is a
suitable alternative system for rapid identification of
members of the genus Streptococcus and of related
genera. S. iniae, which had been characterized
previously by the catalase and esculin test, growth
test in methylene blue, and sodium chloride at
6.5%, was later classified in groups using the Slidex
Strepto-Kit (BioMerieux). Tilapia were identified
in 40 samples by their phenotypic characteristics.
They were determined using the rapid ID 32 Strep
Microtest after incubation at 30 °C and readings at 4
and 24 h.
Infection procedures
An isolate of S. iniae (ATCC-29178), obtained from
the Clinical Microbiology Laboratory of Hebrew
University in Israel, was used to challenge the tilapia.
Injected intraperitoneally into each fish of the tilapia
groups was 0.1 mL of the bacterial suspension
(typically 5 fish per group). For intraperitoneal
injection, an anesthetized fish was placed supine
and supported. The needle was held parallel to the
fish’s spine and inserted cephalad into the midline
of the abdomen, just posterior to the pectoral fins,
and then 3.3 × 105 CFU/0.1 mL S. iniae was injected
intraperitoneally. The sublethal dose was used to
determine disease signs and effects on APPs. The
tilapia in the control groups received THB only.
Experimental design
The study was conducted in 2 sequential experiments
using tilapia. In the first group (the infected group,
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group I), a predetermined sublethal dose of S. iniae
was injected into 24 fish kept in the tanks (8 fish in
each tank). The second group (the handling group,
group II) was exposed to both S. iniae-infection
and handling stress for 15 min additionally. The last
group was the control group. The fish were sampled
on days 7, 14, and 21 after the end of the challenge
trial. Samples for plasma analysis were taken from the
caudal vein of the infected fish and utilized to analyze
CRP, SAA, FB, and TF. Samples were put on ice and
randomized during the assay. The blood taking
process was completed only during the first hour
to keep the manipulation stress level to a minimum
(21). The water temperature was 26.2 ± 0.78 °C and
was observed daily for 28 days, for any abnormal
clinical signs and mortalities.
Method
Measurement of APPs in plasma
Plasma FB was analyzed using the Clauss method
on a STA-SYSTEM analyzer (American Bioproducts
Company, Parsippany, NJ, USA) and multifibrin was
measured using a fibrin timer (Pathteq, Marburg,
Germany). Blood samples taken in sodium citrate
tubes were centrifuged at 2500 rpm for 15 min and
the blood samples were separated. Control plasma N
(code no. ORKE 65) and control plasma P (code no.
OUPZ 21) were used for internal control quantities
and C.V. was determined as 1.8% for this method.
Serum SAA was measured using the
N-high sensitivity CRP with latex-enhanced
immunonephelometric assay on a BN II analyzer
(Dade Behring, Milan, Italy). The assay was carried out
by and immune reaction with covalently coagulated
specific anticores consisting of cell particles shaped
like an envelope. A Cobas Integra autoanalyzer
(Roche Diagnostics, Mannheim, Germany) was used
for measurement. This assay has a detection limit of
6.8 mg/L and coefficient of variation is between 3%7%.
Statistical analyses
The data obtained from the fish at the end of the
study were determined comparatively using Duncan’s
multiple range test. Differences were considered
significant at P < 0.05 or P > 0.05.
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Results
The first experiment (infected group (group I),
which involved the application of a 17% sublethal
dose of S. iniae (3.3 × 105 CFU/0.1 mL) to tilapia
intraperitoneally, resulted in the death of all infected
tilapia within 24 h. In group II, only 21% of the fish
died (out of 24 fish). Mortality and disease signs were
recorded on a daily checklist.
The clinical signs and postmortem examinations
showed darkening of the skin, lethargy in the fish,
and immobility at the pool edges. These were the
first signs observed in the challenged tilapia within
2-3 days. Exophthalmia was not observed in the
infected fish. Histological analysis revealed lesions
in the intestinal area, spleen, posterior kidney, and
brain. Hemorrhages were observed on the skin,
especially at the base of the fins and tail (Figure 1).
Aside from this, hyperemia of the skin and bloody
liquid accumulation in the body cavity were observed
(Figure 2).
Identification
S. iniae was obtained from all of the infected tilapia,
and specific S. iniae colonies on the bacterial cultures
reproduced on THB and BHIA were defined by
observation of gram-positive cocci. Pure colonies
of S. iniae from all of the tissues with histological
evidence of infection were determined using routine
bacteriological culture methods. The cocci were
isolated on THB and BHIA as gray, translucent,
circular, slightly convex, pin-headed colonies,
showing strong beta hemolysis.

Figure 1. Tail region lesions of the tilapia infected experimentally
(original).

The results of the biochemical characterizations
of the isolates with the API rapid ID 32 Strep system
and conventional biochemical tests are summarized
in Table 1.
Table 1. Biochemical features of isolated S. iniae from the full
automatic Rapid ID32 Strep identification system (see ref. 15).
Acid production from sugar

S. iniae

Arabinose

–

Glucose

+

Lactose

–

Mannitol

+

Sorbitol

–

Trehalose

+

Oxidase

–

Biochemical characters

S. iniae

Pyruvate
H2 S

ND

H2 S

ND

Esculin hydrolysis

–

Hippurate
Voges-Proskauer

–

Arginine dihydrolase (ADH)

+

Figure 2. The tumor and inflammatory developments seen in
the organs of tilapia as a consequence of experimental
infection (original).
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APPs in plasma
Plasma results of the infection revealed significant
inflammation responses in both of the experiment
groups. The mean levels were measured in tilapia
given a doses of 3.3 × 105 CFU/0.1 mL. The mean
levels were significantly different between the control
group and those infected with these doses (Table 2).
In groups I and II, the CRP levels in normal tilapia
were 2.97 mg/dL. The mean CRP levels were 3.06 mg/
dL and 3.14 mg/dL at the first week (day 7) after the
infection. The CRP levels increased to a maximum at
10 or 15 days after infection (Figure 3).
In groups I and II, the mean SAA levels were 2.92
and 3.07g/L (control = 2.82 mg/dL) at the first week
(day 7). The SAA concentration in the blood plasma
in the 2 groups showed a higher level after 2 weeks

(day 14) when compared with the control group. SAA
levels decreased in group II (3.05 mg/dL), whereas
the SAA concentration (3.04 mg/dL) was higher at
the last week (day 21) (Figure 4).
In groups I and II, median TF levels at discharge
were 0.59 and 0.62 g/L (control = 0.79 g/L) at the first
week. Increased TF concentrations were observed in
both groups at the end of the second week (Figure 5).
After the first week in group I, the FB values
were 138 g/L and 132 g/L. The levels were low (by
order of 57 and 42 g/L) after days 14 and 21. Group
I did not have low values in the first week, but in the
second and third weeks, significantly low values were
determined. In group II, while the values showed
similarity, in the last stage of experiment (week 3),
all of the values were lower than those in the control
group (Figure 6).

Table 2. Comparative results of the 2 groups of tilapia.
Group I
Sampling period (day)

0*

(Bacteria infection)
7
3.06

Group II

(Bacteria stress)

14

21

0*

7

14

21

3.07

3.12

2.97

3.14

3.08

3.18

CRP (mg/dL)

2.97

SAA (mg/dL)

2.82

2.92

3.00

3.02

2.82

3.02

3.09

3.03

TF (d/L)

0.78

0.60

0.75

0.87

0.78

0.62

0.78

0.88

FB (g/L)

138

132

57

42

138

102

55

38

*: Control group

3.2

3.3

3.2

Control

Bacteria+stress

Serum Amyloid A (mg/dL)

C-Reactive Protein (mg/dL)

Bacteria

3.1

3

2.9

Bacteria+stress
Control

3
2.9
2.8
2.7

7

14
Time (days)

Figure 3. CRP levels in the tilapia.
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3.1

Bacteria

21

7

14
Time (days)

Figure 4. SAA levels in the tilapia.
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Bacteria

Bacteria+stress

Control

Bacteria

Bacteria+stress

Control

140
Fibrinogen (g/L)

Transferrin (d/L)

160
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0

120
100
80
60
40
20

7

14
Time (days)

21

Figure 5. TF levels in the tilapia.

Discussion
Developing challenge models is one of the first
steps in vaccine or pharmaceutical development for
animal diseases. Fish can be infected by bath with a
chosen bacteria concentration; by the introduction of
diseased fish and by intracoelomic or intramuscular
injection. The advantage of the first 2 challenge
techniques is that they replicate the natural route
of the mucosal immunity, which is involved in
protecting fish from the infection. The advantage of
challenging fish by an intramuscular or intracoelomic
injection is that this technique is more replicable and
efficient than the others (22,23). In this study, the
intraperitoneal injection was chosen as challenge
route for its replicability.
Russo et al. (24) developed a challenge model
against S. iniae in rainbow sharks. For this purpose,
researchers determined the lethal dose of bacteria
needed to kill a predetermined percentage of fish in a
fixed period of time. This species has been described
as one of the most frequent in Streptococcus spp.
infections in tilapia. In most studies, a lethal dose
of bacteria/CFUs that should kill 70% of the fish
population in 14 days is chosen as the target bacteria/
CFU dose (23,25). In a study carried out by Bromage
and Owens (26), barramundi (Lates calcarifer) fish
experimentally was infected by S. iniae and morbidity
and mortality rates were determined by injecting a
limited number of bacteria.

7

14
Time (days)

21

Figure 6. FB levels in the tilapia.

In our investigation, experimental fish were
infected with 3.3 × 105/0.1 CFU/mL. However, the
nonlethal dose was determined as a disease dose.
Therefore, mortality due to S. iniae was confirmed at
17% for group I and 21% for group II, within 7 days
(first week) of the bacterial challenge.
Disease signs have been reported for S. iniae
infections of cultured tilapia (27) and experimentally
injected tilapia (22). Dermal hemorrhages on the
body surface (27) and around the mouth, opercula,
base of fins, and anus (22) have been observed in
S. iniae infected moribund tilapia. Perera et al. (22)
also reported loss of orientation, corneal opacity,
exophthalmia, and eye disfigurement.
In this study on tilapia, following the intraperitoneal
challenge, the S. iniae bacterial antigen was observed
in the spleens, kidneys, livers, and skin at all of the
time points tested. The spleens and kidneys of the
tilapia contained lesions, hemorrhages in the fins and
tails (Figure 1), hyperemia on the skin, and bloody
liquid accumulation in the body cavity (Figure 2).
These observations are often assumed to be
identical to those that occur from S. iniae infections.
In addition, disease signs may vary according
to natural and artificial S. iniae infections and
experimental routes of infection. Although some of
the internal and external symptoms obtained from
our study showed similarity to previously published
studies, the effect mechanism of the infection and
385
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alterations of their periods are supposed have been to
be due to the dose of S. iniae used to infect the tilapia
by different modes of infections.

APPs have been shown to vary depending on the
sex, age and size, season, water temperature, pH,
toxicants, infections, and degree of stressors (30).

In the second part of our study, differences in
CRP, SAA, FB, and TF levels, which are used as a
biomarker of the inflammatory response in humans
and other mammals, were evaluated as a possible
indicator of physiological states in fish exposed to
S. iniae infection. The tests are important for the
detection of early stages of disease in fish.

Bayne and Gerwick (4) identified APPs in
mammals and in both teleosts and elasmobranchs,
including CRP, SAP, and several components of the
complement system. Others reported in teleosts
included TF and thrombin. Of these, only CRP was
reported to cause an increase in acute phase plasma.
In trout, a precerebellin-like protein was an APP
with unknown functions. It appeared that, as in
mammals, hepatocytes were the prime source of APP
in fish, and that proinflammatory cytokines induced
transcription of their genes. It is known that the
individual differences determined in plasma protein
profiles among the fish change in accordance with
whether the fish were exposed to genetic differences
or a particular antigene before or not.. We think that
this may be the reason for the differences in our study.

Our data on blood plasma CRP levels showed no
significant differences in either group during the first
week (P < 0.05). While SAA levels increased in the
first and second weeks, levels decreased at the end of
the third week. In the experimental infection model,
observed FB levels were recorded as low for both
groups (Table 2).
The results showed that the concentrations of
these proteins in the blood changed rapidly following
stress and infection. Our study suggested that these
parameters have a specific importance in tilapia
blood plasma.
Jensen et al. (28) examined changes in APPs in
salmonids. In their study, fish were injected with live
A. salmonicida, and then examined for altered levels
of transcripts for SAA, serum amyloid P (SAP), and
albumin. While SAA was undetectable in the control
samples, it was detected at 48 h after the injections,
and at 120 h it reached levels approximately 40 times
those at 48 h.
Gerwick et al. (29) injected rainbow trout
(Oncorhynchus mykiss) with a variety of potential
inflammatory agents, and changes in the
concentrations of plasma proteins were sought in
polyacrylamide gels, in which plasma proteins had
been electrophoresed. They showed increases at day
2 after the injections, and most within 1 week. They
reported the greatest number of changes occurring
after injection with a vibrio bacteria emulsified in
Freund’s incomplete adjuvant.
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Conclusion
In light of the data acquired in this study, infection
with S. iniae of tilapia is strong evidence of the changes
in APPs including inflammation. The APR can be
used for the assessment of general health, including
starvation and growth. Proinflammatory cytokines
and blood proteins of hepatic origin are potential
variables for monitoring the changes induced. APPs
are more useful for monitoring health than cytokines,
because the latter are cleared from circulation within
a few hours, whereas APP levels after a single stimulus
remain unchanged for 48 h or longer. Determination
of APPs can help in monitoring the health of
individual subjects, especially when several acute
phase variables are combined in an index. Moreover,
the significance of APPs as nonspecific variables for
monitoring inflammatory activity has been adopted
in veterinary clinical chemistry.
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